Irreversible electroporation to treat aberrant cell masses

• US 8,992,517 B2
• Filed: 06/24/2009
• Issued: 03/31/2015
• Est. Priority Date: 04/29/2008
• Status: Active Grant

• Current Assignee: Virginia Tech Intellectual Properties, Inc.
• Original Assignee: Virginia Tech Intellectual Properties, Inc.
• Inventors: Davalos, Rafael V., Garcia, Paulo A., Rossmeisl, John H., Robertson, John L., Neal, Robert E.
• Primary Examiner(s): PEFFLEY, MICHAEL F
• Application Number:
  US12/491,151
• Publication Number:
  US 20100030211A1
• Time in Patent Office: 2,106 Days
• Field of Search: 606 27- 37, 606/41, 606/42, 606 48- 50, 607/101, 607/102, 607/116, 604 20- 22, 128/898
• US Class Current: 606/41
• CPC Class Codes: A61B 18/1206 Generators therefor
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2018/00446 Brain
• CPC Class Codes: A61B 2018/00613 Irreversible electroporation reversible electroporation A61N1/327
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/327 for enhancing the absorption properties of tissue, e.g. by electroporation
• CPC Class Codes: C12N 13/00 Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Abstract

The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. The invention can be used to treat solid tumors, such as brain tumors. The methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors.

Claims

1. A method of treating a subject suffering from a brain tumor, said method comprising:

creating a skull defect to gain access to the brain tumor;

positioning through the skull defect at least one electrode in or adjacent the brain tumor, the electrode having a blunt tip to minimize damage of brain tissue during positioning, wherein the blunt tip has an opening;

deploying through the opening another electrode having a pointed tip adapted to pierce the tumor tissue,

causing multiple electrical pulses to be emitted from the positioned electrode into the tumor in an amount sufficient to cause irreversible electroporation of tissue cells of the brain tumor.

2. The method of claim 1, wherein the electrical pulses are each 50 microseconds or less.

3. The method of claim 1, wherein the electrical pulses are each 25 microseconds or less.

4. The method of claim 1, further comprising:

applying an excitation voltage signal to the tissue cells of the brain tumor prior to the step of causing multiple electrical pulses to be emitted from the electrode;

measuring an electrical response to the excitation voltage signal and determining specific conductivity of the tissue cells;

determining at least one pulse parameter based on the specific conductivity of the tissue cells.

5. The method of claim 4, wherein the step of applying at least one excitation voltage signal includes applying an AC voltage signal whose strength is insufficient to cause irreversible electroporation of the tumor tissue cells.

6. The method of claim 4, further comprising:

applying one or more test voltage signals during the step of causing multiple electrical pulses to be emitted from the positioned electrode; and

adjusting at least one pulse parameter based on the applied test voltage signals.

7. The method of claim 4, further comprising measuring the response to the excitation voltage signal at substantially the same frequency as the excitation frequency of the excitation voltage signal.

8. The method of claim 1, further comprising adjusting one or more electrically conductive regions of the electrode.

9. The method of claim 8, where the one or more electrically conductive regions of the electrode are adjusted in real-time.

10. The method of claim 1, further comprising cooling the positioned electrode while the multiple electrical pulses are emitted.

11. A method of treating a brain tumor of a living subject with IRE, said method comprising:

providing at least one pair of electrodes;

implanting at least one electrode into or adjacent the brain tumor of the subject,

performing a pulse protocol causing multiple electrical pulses to be emitted from the implanted electrode into the brain tumor to cause IRE of tissue cells in the brain tumor, wherein the pulse protocol includes delivery of a total charge to the brain tumor of less than about 22.5 mC per pair of electrodes, wherein the pulse protocol is based on determining specific conductivity of the tissue cells in the brain tumor.

12. The method of claim 11, wherein the current is monitored in real-time and, based on that monitoring, at least one pulse parameter is changed.

13. The method of claim 11, wherein the pulse protocol includes at least one pulse parameter that is at least one of voltage, pulse length, and number of pulses.

14. A method of treating a living subject suffering from a tumor, said method comprising:

implanting at least one electrode into or adjacent the tumor within the body of the subject,

applying at least one excitation voltage signal to the tumor and measuring the response,

determining specific conductivity (σ

) from the response to the excitation voltage signal,

using the specific conductivity (σ

) to determine at least one pulse parameter,

using the determined pulse parameter, causing multiple electrical pulses to be emitted from the implanted electrode into the tumor to cause irreversible electroporation of tissue cells in the tumor.

15. The method of claim 14, comprising limiting the total charge to the tumor to about 22.5 mC or less per pair of electrodes.

16. The method of claim 14, wherein the at least one pulse parameter is at least one of pulse voltage, pulse length and number of pulses.

17. The method of claim 14, wherein the step of applying at least one excitation voltage signal includes applying at least one non-electroporating electric pulse in the range of about 50 V/cm or less.

18. The method of claim 14, wherein the electrical pulses are each 50 microseconds or less.

19. The method of claim 14, wherein the electrical pulses are each 25 microseconds or less.

20. The method of claim 14, wherein the step of applying at least one excitation voltage signal includes applying an AC voltage signal whose strength is insufficient to cause irreversible electroporation of the tumor tissue cells.

21. The method of claim 14, further comprising:

applying one or more test voltage signals during the step of causing multiple electrical pulses to be emitted from the implanted electrode; and

adjusting at least one pulse parameter based on the applied test voltage signals.

22. The method of claim 21, wherein the one or more test voltage signals are applied using the positioned electrode.

23. The method of claim 14, further comprising measuring the response to the excitation voltage signal at substantially the same frequency as the excitation frequency of the excitation voltage signal.

24. The method of claim 14, wherein the step of implanting at least one electrode includes implanting the electrode having a blunt tip.

25. The method of claim 24, wherein the blunt tip has an opening, and the step of implanting includes deploying another electrode through the opening.

26. The method of claim 25, wherein the blunt tip has an opening, and the step of implanting includes deploying through the opening another electrode having a pointed tip adapted to pierce the tumor tissue.

27. The method of claim 14, further comprising adjusting one or more electrically conductive regions of the electrode.

28. The method of claim 14, further comprising cooling the implanted electrode while the multiple electrical pulses are emitted.

29. The method of claim 14, wherein the step of measuring the response includes measuring current.

30. The method of claim 14, further comprising delivering an anti-swelling agent to reduce edema.

31. The method of claim 14, further comprising:

establishing an electrode shape factor; and

determining physical dimensions of the tumor;

wherein the determining of the specific conductivity is based on the shape factor, physical dimensions of the tumor, and the response to the excitation voltage signal.